Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization
Liver Cancer
DOI:
10.14218/jcth.2023.00099
Publication Date:
2023-07-07T02:12:47Z
AUTHORS (9)
ABSTRACT
Background and AimsTo validate prognostic performance of the China liver cancer (CNLC) staging system as well to compare these parameters with those Barcelona Clinic Liver Cancer (BCLC) for Chinese hepatocellular carcinoma (HCC) treated transarterial chemoembolization (TACE).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....